|
1
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
de Gramont A, Figer A, Seymour M, et al:
Leucovorin and fluorouracil with or without oxaliplatin as
first-line treatment in advanced colorectal cancer. J Clin Oncol.
18:2938–2947. 2000.PubMed/NCBI
|
|
3
|
Douillard JY, Cunningham D, Roth AD, et
al: Irinotecan combined with fluorouracil compared with
fluorouracil alone as first-line treatment for metastatic
colorectal cancer: a multicentre randomised trial. Lancet.
355:1041–1047. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Hochster HS, Hart LL, Ramanathan RK, et
al: Safety and efficacy of oxaliplatin and fluoropyrimidine
regimens with or without bevacizumab as first-line treatment of
metastatic colorectal cancer: results of the TREE Study. J Clin
Oncol. 26:3523–3529. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Van Cutsem E, Rivera F, Berry S, et al:
Safety and efficacy of first-line bevacizumab with FOLFOX, XELOX,
FOLFIRI and fluoropyrimidines in metastatic colorectal cancer: the
BEAT study. Ann Oncol. 20:1842–1847. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Mazzio EA and Soliman KF: In vitro
screening for the tumoricidal properties of international medicinal
herbs. Phytother Res. 23:385–398. 2009. View Article : Google Scholar :
|
|
7
|
Desai AG, Qazi GN, Ganju RK, et al:
Medicinal plants and cancer chemoprevention. Curr Drug Metab.
9:581–591. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Ball DW: The chemical composition of maple
syrup. J Chem Educ. 84:U1647–U1648. 2007. View Article : Google Scholar
|
|
9
|
Davison RM and Young H: Abscisic acid
content of xylem sap. Planta. 109:95–98. 1973. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Perkins TD and van den Berg AK: Maple
syrup - production, composition, chemistry, and sensory
characteristics. Adv Food Nutr Res. 56:101–143. 2009. View Article : Google Scholar
|
|
11
|
Taga A, Sato A, Suzuki K, Takeda M and
Kodama S: Simple determination of a strongly aromatic compound,
sotolon, by capillary electrophoresis. J Oleo Sci. 61:45–48. 2012.
View Article : Google Scholar
|
|
12
|
Taga A and Kodama S: Analysis of reducing
carbohydrates and fructosyl saccharides in maple syrup and maple
sugar. Chromatographia. 75:1009–1016. 2012. View Article : Google Scholar
|
|
13
|
Li L and Seeram NP: Maple syrup
phytochemicals include lignans, coumarins, a stilbene, and other
previously unreported antioxidant phenolic compounds. J Agric Food
Chem. 58:11673–11679. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Li L and Seeram NP: Further investigation
into maple syrup yields 3 new lignans, a new phenylpropanoid, and
26 other phytochemicals. J Agric Food Chem. 59:7708–7716. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Li LY and Seeram NP: Quebecol, a novel
phenolic compound isolated from Canadian maple syrup. J Funct
Foods. 3:125–128. 2011. View Article : Google Scholar
|
|
16
|
Gonzalez-Sarrias A, Li L and Seeram NP:
Effects of maple (Acer) plant part extracts on proliferation,
apoptosis and cell cycle arrest of human tumorigenic and
non-tumorigenic colon cells. Phytother Res. 26:995–1002. 2012.
View Article : Google Scholar
|
|
17
|
Gonzalez-Sarrias A, Ma H, Edmonds ME and
Seeram NP: Maple polyphenols, ginnalins A-C, induce S- and
G2/M-cell cycle arrest in colon and breast cancer cells mediated by
decreasing cyclins A and D1 levels. Food Chem. 136:636–642. 2013.
View Article : Google Scholar
|
|
18
|
Apostolidis E, Li LY, Lee C and Seeram NP:
In vitro evaluation of phenolic-enriched maple syrup extracts for
inhibition of carbohydrate hydrolyzing enzymes relevant to type 2
diabetes management. J Funct Foods. 3:100–106. 2011. View Article : Google Scholar
|
|
19
|
Legault J, Girard-Lalancette K, Grenon C,
Dussault C and Pichette A: Antioxidant activity, inhibition of
nitric oxide overproduction, and in vitro antiproliferative effect
of maple sap and syrup from Acer saccharum. J Med Food. 13:460–468.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Nagai N, Ito Y and Taga A: Comparison of
the enhancement of plasma glucose levels in type 2 diabetes Otsuka
Long-Evans Tokushima Fatty rats by oral administration of sucrose
or maple syrup. J Oleo Sci. 62:737–743. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Siemens H, Jackstadt R, Hunten S, et al:
miR-34 and SNAIL form a double-negative feedback loop to regulate
epithelial-mesenchymal transitions. Cell Cycle. 10:4256–4271. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Li Y, Bavarva JH, Wang Z, et al: HEF1, a
novel target of Wnt signaling, promotes colonic cell migration and
cancer progression. Oncogene. 30:2633–2643. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Stuckel JG and Low NH: The chemical
composition of 80 pure maple syrup samples produced in North
America. Food Res Int. 29:373–379. 1996. View Article : Google Scholar
|
|
24
|
Kang JS, Park IH, Cho JS, et al:
Epigallocatechin-3-gallate inhibits collagen production of nasal
polyp-derived fibroblasts. Phytother Res. 28:98–103. 2014.
View Article : Google Scholar
|
|
25
|
Zhai X, Chi J, Tang W, et al: Yellow wine
polyphenolic compounds inhibit matrix metalloproteinase-2, -9
expression and improve atherosclerotic plaque in
LDL-receptor-knockout mice. J Pharmacol Sci. 125:132–141. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Singh T and Katiyar SK: Green tea
polyphenol, (−)-epigallo-catechin-3-gallate, induces toxicity in
human skin cancer cells by targeting β-catenin signaling. Toxicol
Appl Pharmacol. 273:418–424. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Zhao M, Tang SN, Marsh JL, Shankar S and
Srivastava RK: Ellagic acid inhibits human pancreatic cancer growth
in Balb c nude mice. Cancer Lett. 337:210–217. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Tsai CM, Sun FM, Chen YL, Hsu CL, Yen GC
and Weng CJ: Molecular mechanism depressing PMA-induced invasive
behaviors in human lung adenocarcinoma cells by cis- and
trans-cinnamic acid. Eur J Pharm Sci. 48:494–501. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Chen Y, Zheng L, Liu J, et al: Shikonin
inhibits prostate cancer cells metastasis by reducing matrix
metalloproteinase-2/-9 expression via AKT/mTOR and ROS/ERK1/2
pathways. Int Immunopharmacol. 21:447–455. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Kuo CL, Lai KC, Ma YS, Weng SW, Lin JP and
Chung JG: Gallic acid inhibits migration and invasion of SCC4 human
oral cancer cells through actions of NFκB, Ras and matrix
metallo-proteinase-2 and -9. Oncol Rep. 32:355–361. 2014.PubMed/NCBI
|
|
31
|
Xu Q, Ma J, Lei J, et al: α-Mangostin
suppresses the viability and epithelial-mesenchymal transition of
pancreatic cancer cells by downregulating the PI3K/Akt pathway.
Biomed Res Int. 2014:5463532014. View Article : Google Scholar
|
